These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1148032)

  • 41. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
    Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
    Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
    Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
    Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypolipidemic, uricosuric, and thyroxine-displacing effects of MK-185 (halofenate).
    Morgan JP; Bianchine JR; Hsu TH; Margolis S
    Clin Pharmacol Ther; 1971; 12(3):517-24. PubMed ID: 4936037
    [No Abstract]   [Full Text] [Related]  

  • 44. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 45. Halofenate: effectiveness of two dosage forms and two dose schedules.
    Hutchison JC; Wilkinson WH
    Atherosclerosis; 1974; 19(3):417-28. PubMed ID: 4133379
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemia.
    Boberg J; Boberg M; Gross R; Grundy S; Augustin J; Brown V
    Atherosclerosis; 1977 Aug; 27(4):499-503. PubMed ID: 884004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Does magnesium-orotate improve the effect of lipid lowering drugs?].
    Irsigler K; Flegel U; Kühn P; Schubert H; Iván E; Biro L; Székely L
    Int J Clin Pharmacol; 1973 Aug; 8(1):85-95. PubMed ID: 4727450
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets.
    Huzoor-Akbar ; Ardlie NG
    Thromb Haemost; 1977 Oct; 38(3):612-9. PubMed ID: 579507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diurnal lipid and lipoprotein profiles in hypertriglyceridemic patients with bezafibrate and clofibrate.
    Oster P; Lang PD; Vollmar J; Schlierf G
    Res Exp Med (Berl); 1986; 186(6):435-41. PubMed ID: 3823619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemia.
    Bielmann P; Brun D; Moorjani S; Gagnon MA; Tétreault L; Lupien PJ
    Int J Clin Pharmacol Biopharm; 1977 Apr; 15(4):166-71. PubMed ID: 192685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Halofenate. Its selection and trial as a primary uricosuric agent.
    Bluestone R; Campion D; Klinenberg JR
    Arthritis Rheum; 1975; 18(6 Suppl):859-62. PubMed ID: 1106434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial.
    Rabkin SW; Hayden M; Frohlich J
    Atherosclerosis; 1988 Oct; 73(2-3):233-40. PubMed ID: 3056431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma protein concentrations in hypertriglyceridaemic subjects. Effect of clofibrate and comparison with normal subjects.
    Ballantyne FC; Morrison BA; Ballantyne D; Dryburgh FJ; Epenetos AA
    Clin Chim Acta; 1978 Jul; 87(1):43-7. PubMed ID: 668144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of halofenate on thyroxine-binding globulin (TBG) and thyroid function tests using TBG].
    Miyamoto M; Inoue K; Kojima T; Nagashima N; Ban Y
    Horumon To Rinsho; 1976; 24(3):265-9. PubMed ID: 61080
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man.
    Goodman DS; Noble RP; Dell RB
    J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
    Lithell H; Vessby B; Boberg J; Hellsing K
    Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1284-7. PubMed ID: 5023326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.